When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Focal atrial tachycardia

Última revisão: 15 Jun 2025
Última atualização: 04 Jun 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • cardiac disease
Detalhes completos

Outros fatores diagnósticos

  • medications
  • palpitations
  • fatigue, weakness
  • chest pain
  • shortness of breath, cough
  • nausea, vomiting
  • lightheadedness, syncope
  • rales
  • edema
Detalhes completos

Fatores de risco

  • substance misuse (alcohol ingestion/withdrawal, cocaine, amphetamines)
  • digoxin toxicity
  • previous cardiac surgery to correct congenital heart defects
  • coronary artery disease
  • exacerbation of chronic lung disease
  • theophylline
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • ECG
  • digoxin level
  • theophylline level
  • CXR
  • electrolytes
  • toxicology screen
Detalhes completos

Investigações a serem consideradas

  • vagal maneuvers, adenosine
  • thyroid-stimulating hormone
  • echocardiogram
  • ambulatory 24-hour (Holter) ECG or event recorder
  • electrophysiologic study (EPS)
Detalhes completos

Algoritmo de tratamento

Inicial

adult: undifferentiated supraventricular tachycardia

AGUDA

adult: focal AT; digoxin excess not suspected

adult: focal AT; digoxin toxicity suspected

child

CONTÍNUA

adult: sustained or recurrent focal AT

Colaboradores

Autores

Danesh Kella, MBBS, FHRS

Assistant Professor

Department of Cardiovascular Diseases

Division of Heart Rhythm

Mayo Clinic

Jacksonville

FL

Declarações

DK receives honoraria from Zoll Medical.

Agradecimentos

Dr Danesh Kella would like to gratefully acknowledge Dr Sarah Stahmer, previous contributor to this topic.

Revisores

Kathryn L. Berlacher, MD, MS

Assistant Professor and Cardiology Fellowship Program Director

University of Pittsburgh Medical Center

Pittsburgh

PA

Declarações

KLB declares that she has no competing interests.

Mehak Dhande, MD

Clinical Cardiac Electrophysiology Fellow

University of Pittsburgh Medical Center

Pittsburgh

PA

Declarações

MD declares that she has no competing interests.

Amal Mattu, MD

Associate Professor of Emergency Medicine

University of Maryland Medical Center

Baltimore

MD

Declarações

AM declares that he has no competing interests.

Vias Markides, MB(Hons), BS(Hons), MD, FRCP

Consultant Cardiologist

Royal Brompton & Harefield NHS Trust

Imperial College London

London

UK

Declarações

VM declares that he has no competing interests.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016 Apr 5;67(13):e27-e115.Texto completo  Resumo

Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020 Feb 1;41(5):655-720.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Focal atrial tachycardia images
  • Diagnósticos diferenciais

    • Sinus tachycardia
    • AV node re-entrant tachycardia
    • AV re-entrant tachycardia or accessory pathway mediated tachycardia
    Mais Diagnósticos diferenciais
  • Diretrizes

    • JCS/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias
    • 2019 ESC guidelines for the management of patients with supraventricular tachycardia
    Mais Diretrizes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal